Using an intracardiac mouse model of metastasis, shRNA-mediated knockdown of both ABL1 and ABL2 in bone tropic triple-negative breast cancer cells decreased metastasis to the bone and increased overall survival [11]. This evidence concerns the gene ABL2 and triple-negative breast carcinoma.